Valion Bio, Inc. Increase (Decrease) in Inventories
Valion Bio, Inc. (VBIO) reported Increase (Decrease) in Inventories of $750.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-14
- Valion Bio, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $0.00.
- Valion Bio, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $750.00K.
- Valion Bio, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$16.17M, a 179744.44% decline year-over-year.
- Valion Bio, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$85.00K.
- Valion Bio, Inc. increase (decrease) in inventories for fiscal 2025 was -$16.25M.
- Valion Bio, Inc. increase (decrease) in inventories for fiscal 2024 was $0.00.
- Valion Bio, Inc. increase (decrease) in inventories for fiscal 2023 was -$75.00K, a 117.28% decline from fiscal 2022.
- Valion Bio, Inc. increase (decrease) in inventories for fiscal 2022 was $434.00K, a 139.78% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 1 month | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $750.00K 10-Q · filed 2026-08-14 | -$15.42M derived: sum of 3 quarters · filed 2026-08-14 | -$15.50M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $750.00K 10-Q · filed 2026-05-14 | -$15.42M derived: sum of 2 quarters · filed 2026-05-14 | -$15.50M derived: sum of 3 quarters · filed 2026-05-14 | -$15.50M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$16.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$16.25M derived: sum of 2 quarters · filed 2026-03-30 | -$16.25M derived: sum of 3 quarters · filed 2026-08-14 | -$16.25M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$85.00K derived: sum of 2 quarters · filed 2026-08-14 | -$85.00K 10-Q · filed 2025-11-14 | -$76.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | -$36.00K 10-Q · filed 2025-08-14 | $9.00K derived: sum of 3 quarters · filed 2026-08-14 | -$26.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | -$13.00K 10-Q · filed 2025-05-15 | $9.00K derived: sum of 2 quarters · filed 2026-05-14 | -$26.00K derived: sum of 3 quarters · filed 2026-05-14 | -$14.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$26.00K derived: sum of 2 quarters · filed 2026-03-30 | -$14.00K derived: sum of 3 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | -$83.00K 10-K · filed 2025-03-21 | |||
| 2024-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$23.00K derived: sum of 2 quarters · filed 2025-11-14 | -$9.00K 10-Q · filed 2025-11-14 | -$149.00K derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $26.00K 10-Q · filed 2025-08-14 | -$114.00K derived: sum of 3 quarters · filed 2025-08-14 | -$174.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-15 | -$126.00K derived: sum of 2 quarters · filed 2025-05-15 | -$186.00K derived: sum of 3 quarters · filed 2025-05-15 | -$141.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$200.00K derived: sum of 2 quarters · filed 2025-03-21 | -$155.00K derived: sum of 3 quarters · filed 2025-03-21 | -$75.00K 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$15.00K derived: sum of 2 quarters · filed 2024-11-14 | $65.00K 10-Q · filed 2024-11-14 | $167.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $125.00K 10-Q · filed 2024-08-14 | $227.00K derived: sum of 3 quarters · filed 2024-08-14 | $155.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $80.00K 10-Q · filed 2024-05-15 | $182.00K derived: sum of 2 quarters · filed 2024-05-15 | $110.00K derived: sum of 3 quarters · filed 2024-05-15 | $496.00K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $30.00K derived: sum of 2 quarters · filed 2024-03-25 | $416.00K derived: sum of 3 quarters · filed 2024-03-25 | $434.00K 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $314.00K derived: sum of 2 quarters · filed 2023-11-14 | $332.00K 10-Q · filed 2023-11-14 | $471.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $404.00K 10-Q · filed 2023-08-14 | $543.00K derived: sum of 3 quarters · filed 2023-08-14 | $543.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $18.00K 10-Q · filed 2023-05-15 | $157.00K derived: sum of 2 quarters · filed 2023-05-15 | $157.00K derived: sum of 3 quarters · filed 2023-05-15 | $206.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-01-31 | $18.00K 10-Q · filed 2022-05-16 | |||||||
| 2021-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $139.00K derived: sum of 2 quarters · filed 2023-03-31 | $188.00K derived: sum of 3 quarters · filed 2023-03-31 | $181.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $49.00K derived: sum of 2 quarters · filed 2022-11-14 | $42.00K 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $42.00K 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |